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Abstract: Life cycle assessment (LCA) evaluates the environmental impact of a product based on
the materials and processes used to manufacture the item as well as the item’s use and disposal.
The objective of this LCA was to evaluate and compare the environmental impact of a metered dose
inhaler, specifically the Proventil® HFA inhaler (Merk & Co., Inc., Kenilworth, NJ, USA), and an
electric nebulizer, specifically the DeVilbiss Pulmo-Aide® nebulizer (DeVilbiss, Port Washington, NY,
USA). GaBi LCA software was used to model the global warming potential (GWP) of each product
by using substantiated data and well-justified assumptions for the components, manufacturing,
assembly, and use of both devices. The functional unit used to model each device was one dose of the
active drug, albuterol sulfate. The inhaler’s GWP, 0.0972 kg CO2 -eq, was greater than the nebulizer’s
even when uncertain parameters were varied ±100×. During the use phase ofa the inhaler, which
accounted for approximately 96% of the inhaler’s total GWP, HFA 134a is used as a propellant to
deliver the drug. The total GWP for the electric nebulizer was 0.0294 kg CO2 -eq assuming that
the mouthpiece was cleaned in a dishwasher, while it was 0.0477 kg CO2 -eq when the nebulizer
mouthpiece was hand washed between uses. The GWP breakeven scenario between dishwashing
and hand washing occurred when the mouthpiece accounted for 10% of the dishwasher load.
Keywords: life cycle assessment (LCA); metered dose inhaler (MDI); nebulizer; chronic obstructive
pulmonary disease (COPD); global warming potential (GWP); carbon dioxide (CO2 )

1. Introduction
According to the World Health Organization (WHO), “Climate change is the greatest threat to
global public health in the 21st century” [1]. Increasingly greater emphasis has been accorded to this
issue in recent years. At the same time, the inverse relationship is also attracting attention: ironically,
approximately 10% of global greenhouse gas (GHG) emissions are generated by the healthcare
sector alone (8% of total GHG emissions in the U.S.) [2–4]. Yet, the environmental costs of devices,
procedures, and facilities in the healthcare sector are often overlooked in spite of significant local,
national, and global impacts, including energy and material consumption and emissions that adversely
impact environmental and human health [5]. Accordingly, there is significant opportunity for systemic
improvements leading to reductions in health-related environmental impacts. In particular, routine
inclusion of life cycle criteria is needed as part of device selection to account for total negative
healthcare-associated impacts rather than impacts at a single point in time, e.g., during device use [6].
Unfortunately, limited research is currently available describing the environmental costs associated
with the healthcare system [5]. Thus, before improvements can be implemented in the healthcare
sector, it is imperative to develop a deeper understanding of the associated environmental impacts.
One tool that, while still relatively rare, is being increasingly utilized is life cycle assessment.
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Life cycle assessment (LCA) provides a quantitative, systematic approach for determining the
environmental costs of a product or system over its life cycle, including raw material extraction,
production, transportation and distribution, use, and final disposal. This approach can provide
a complete “cradle-to-grave” (tracking impacts from extraction to disposal) or “cradle-to-cradle”
(tracking impacts from extraction to recycling for reuse) assessment, or can be used to focus on
individual phases of the life cycle. LCA is now a common tool to evaluate technologies and
systems from an environmental impact standpoint and is being increasingly used to guide design,
manufacturing, and logistics. The International Organization for Standardization has published an
LCA standard, ISO 14040 [7], which establishes LCA principles and framework.
The specific objective of this study was to evaluate the environmental impacts of systems designed
to deliver inhaled medication for treatment of chronic obstructive pulmonary disease (COPD) using
LCA. Globally, COPD is the third leading cause of death, with disproportionate effects in developing
regions with unreliable electricity [8–10]. COPD also accounts for billions in annual economic losses
due to lost workdays [11]. Thus, it is critical that effective and affordable COPD treatments are
available to people around the world. It is also imperative to consider the environmental impacts of
these treatments, which have yet to be evaluated. In the U.S. and other developed countries, portable
metered dose inhalers are most commonly used to treat COPD, while electric nebulizers are most often
used in a home or medical facility. Thus, a comparative LCA of an inhaler and nebulizer system was
performed in this study. This research is the only known LCA comparing inhalers and nebulizers.
It will help to inform COPD treatment device design improvements, and can contribute to calculations
of carbon market offsets of COPD treatment devices.
2. Materials and Methods
2.1. Goal and Scope Definition
The purpose of this study was to perform a comparative LCA to evaluate the cradle-to-use phase
global warming potential (GWP) of a metered dose inhaler, specifically the Proventil® HFA inhaler,
relative to an electric nebulizer, specifically the DeVilbiss Pulmo-Aide® nebulizer (both are pictured
in Figure S1 in the Supplementary Data). Both of the devices are used for the treatment of COPD via
delivery of the inhalation aerosol drug albuterol sulfate.
The frequency of administration of bronchial dilation drugs (e.g., albuterol sulfate) to a patient
varies between the inhaler and nebulizer methods of delivery based on the severity of asthma and
the concentration of the drug that is delivered. Thus, to compare the environmental impacts of the
inhaler and nebulizer, the functional unit in this study was defined as one dose of albuterol sulfate.
A single inhaler can be used to supply 100 doses (2 puffs per dose). The nebulizer was modeled as
being able to administer 2000 doses assuming 2–4 treatments per week and a 10 year average lifespan
of the compressor [12].
An inventory analysis of the manufacturing processes and materials used to produce the two
drug delivery devices was conducted, and the inventories were then modeled using GaBi Product
Sustainability software (v. 6) to calculate the products’ environmental impact quantified as GWP from
cradle through use phase. Transportation and packaging were excluded from the analysis based on
preliminary results, which demonstrated that they played insignificant roles in GWP impacts. When
possible, pre-defined manufacturing processes included in the GaBi software were used to model the
devices since these processes are typically well documented and vetted in terms of material and energy
flows. Default process selections used U.S. data, while European process data was used when U.S.
data was unavailable.
For consistency, the “US Electricity grid mix PE” GaBi process was used to model all of the
electricity inputs. This electricity mix includes the U.S. national average mix of 0.4% geothermal,
0.3% wind, 6.4% hydro, 1.7% waste and biomass, 20% nuclear, 50.7% coal, 2.5% heavy fuel oil, and 20%
natural and blast furnace gas energy sources.
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2.2. Inventory Analysis: Metered Dose Inhaler
For each drug delivery device, the inventory was prepared by disassembling the device and
determining the mass and major composition of each component, as shown for the metered dose
inhaler in Table 1. The Proventil® HFA inhaler can be categorized into six major components: the active
substance, propellant, surfactant, metering valve, actuator, and canister [13]. The following sections
describe the assumptions for the manufacture and assembly of each component used to model the
device using manufacturing processes available in the GaBi Professional + Extension XVII database (as
shown in the inventory flow diagram in Figure S2 in the Supplementary Data). An inhaler assembly
energy input of 1 MJ (0.001 MJ/dose) was estimated based on other manufacturing processes built
into the GaBi database.
Table 1. Components of the metered dose inhaler (MDI) including mass (total of 23.4 g), composition,
and manufacturing process used in the GaBi life cycle assessment (LCA) model.
Major Components of
the MDI

Mass (g)

Composition

GaBi Model
Manufacturing Process

Active substance

0.02

Albuterol Sulfate

N/A 1

Propellant

6.68

HFA-134a

N/A 1

Surfactant

0.002

Oleic acid and ethanol

N/A 2

1.10
0.13
0.30
0.09
0.26
0.39
0.07
<0.01

Aluminum
High Density Polyethylene (HDPE)
Stainless Steel
Steel Wire
Stainless Steel
Stainless Steel
Nitrile Rubber
Nitrile Rubber

Stamping and Bending
Plastic Injection Molding
Deep Drawing
Auto Coiler
Stamping and Bending
Stamping and Bending
Plastic Injection Molding
N/A 2

8.62
1.20

Polypropylene
Polypropylene

Plastic Injection Molding
Plastic Injection Molding

4.56

Aluminum

Deep Drawing

Metering Valve
Ferrule
Ferrule Gasket
Valve Stem
Compression Spring
Tank
Bottle Emptier
Diaphragm
Tank Seal
Actuator
Actuator
Actuator Cap
Canister
1

Not applicable (N/A) as the manufacturing process was modeled as directly combining the materials to output
the component using 1 MJ assembly energy input/device; 2 Not applicable (N/A) as this component was excluded
from the model due to negligible mass.

2.2.1. Active Substance
The active bronchodilator substance is albuterol sulfate, (C13 H21 NO3 )2 ·H2 SO4 (also known as
salbutamol sulfate, the WHO recommended name). Albuterol sulfate makes up 0.3% of the net weight
of the drug [14]. Detailed information about albuterol sulfate and its production is not publicly
available. However, since the functional unit in this analysis was a single dose of the drug, an exact
representation of the albuterol sulfate itself was not necessary in this comparative LCA since both
devices use albuterol sulfate, and the device impacts were normalized to the functional unit of a single
dose. Accordingly, a new GaBi process was developed to represent the active substance. A conservative
placeholder, chlorodifluoromethane (CHF2 Cl, also known as HCFC-22 or R22), was used to model the
active ingredient. HCFC-22 is commonly used as a propellant and is characterized by a high GWP
(up to 1700× that of CO2 [15]); as such, it was anticipated to have greater negative GWP impacts
than albuterol sulfate. If the GWP impacts of HCFC-22 were shown to be negligible in the model in
comparison to other components, then negligible impacts from albuterol sulfate could also be assumed.
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Microionizers using compressed air are used to convert the active drug into an ultra-fine
powder [13], so for production of the active substance, a compressed air manufacturing process
was used in the GaBi model.
2.2.2. Propellant
The inhaler relies on the propellant to forcefully deliver an aerosolized cloud of the drug (1%
albuterol sulfate in saline solution combined with surfactant) to the user. The propellant in Proventil®
HFA is hydrofluoroalkane-134a (HFA-134a, or 1,1,1,2-tetrafluoroethane, C2 H2 F4 ), which represents
99.7% of the net weight of the drug formulation [14]. Production of the propellant was modeled in GaBi
as a reaction between hydrogen fluoride (HF) and trichloroethylene (C2 HCl3 ) in a closed system [16]:
4HF + C2 HCl3 → CH2 FCF3 + 3HCl
Based on stoichiometry, the chemical reaction to yield 1 kg of HFA-134a requires 0.784 kg of HF
and 0.969 kg of C2 HCl3 . When the reactants are in vapor form, the temperature at which the reaction
occurs is 380 ◦ C; assuming room temperature initially, this would require 495 kJ of thermal energy
input. The reaction also produces 2.14 kg of HCl, which was modeled as being recoverable for reuse
for other purposes.
2.2.3. Surfactant
The surfactant allows the active substance and the propellant to mix together, creating the
inhalation solution. For the aerosol drug in Proventil® HFA, oleic acid and ethanol compose the
surfactant [13]. However, as mass of the surfactant is approximately 10% of the active substance (less
than 0.01% of the total mass of the inhaler), the surfactant was considered negligible and was excluded
from the model.
2.2.4. Metering Valve
The metering valve controls the dose of drug released in a single inhaler puff. It consists of the
ferrule, ferrule gasket, valve stem, compression spring, tank, bottle emptier, diaphragm, and tank seal.
Stamping was used to model production of the aluminum ferrule in GaBi. The ferrule gasket
was modeled as polyethylene composition manufactured by using injection molding. The valve
stem, spring, tank, and bottle emptier were modeled as 316 stainless steel material. While valve
stems can be manufactured using metal injection molding [17,18], this process is not built into the
GaBi database, so deep drawing was used instead. The compression spring is manufactured using
an auto-coiling machine, which has a similar energy consumption to steel stamping and bending,
as employed in the GaBi model. The tank and bottle emptier are manufactured via press forming,
which was assumed to be similar to stamping and bending, as used in the GaBi model. Nitrile
rubber is used to produce the diaphragm and tank seal. In GaBi, the rubber was modeled as a blend
of 50% acrylonitrile and 50% butadiene (the acrylonitrile content in rubber typically ranges from
20–50%) [19,20]. The polymerization process was condensed into a single phase and was assumed to
have a similar energy consumption to the acrylonitrile-butadiene-styrene copolymer resin in GaBi [21].
The mass of the tank seal was less than 0.01 g (<0.04% of the total mass of the inhaler), and was thus
assumed to be negligible and was excluded in the model.
2.2.5. Actuator
The actuator (which controls the inhaler movement) and actuator cap were modeled as
polypropylene parts manufactured using plastic injection molding.
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2.2.6. Canister
The canister containing the drug was modeled using aluminum deep drawing manufacturing.
To prevent the albuterol sulfate and HFA-134a from reacting with the aluminum, the interior surface
of the canister and valve components are coated with a thin dual-layer coating (<1 µm) consisting of
a vapor-deposited inorganic layer and a fluorine layer [22]. The mass of the coating in the device is
negligible, and was thus excluded from the model.
2.2.7. Use Phase
During the inhaler’s use phase, the medicine canister is placed into the actuator and the device is
primed by shaking before use. A single dose of the drug is administered in the form of two puffs of
the inhaler. In the GaBi LCA model, the sole input for the use phase was the inhaler itself. All of the
propellant associated with each puff was assumed to be released to the atmosphere (i.e., no absorption
of the propellant itself in the body in this conservative model), with an associated GWP impact.
2.3. Inventory Analysis: Electric Nebulizer
An inventory of the components of the DeVilbiss Pulmo-Aide® nebulizer was produced by
disassembling the device and determining the mass and major composition of each component,
as listed in Table 2. The major components of the nebulizer were grouped into the active substance
(as described previously), exterior shell, stator (including core, coils and cover), rotor (including
squirrel cage, ball bearings, and central shaft), suction chamber, fan (including fan, fan housing,
and cross brace), medicine delivery (including mouthpiece, medical tubing, and medicine chamber),
and power cord.
Table 2. Components of the electric nebulizer (EN) including mass (total of 2726 g), composition, and
manufacturing process used in the life cycle assessment (LCA) model.
Major Components of
the EN

Mass (g)

Composition

GaBi Model
Manufacturing Process

Active Substance

0.003 2

Albuterol Sulfate

N/A 1

Exterior Shell

1102

Acrylonitrile Butadiene Styrene (ABS)

Plastic Injection Molding

539
135
182

Steel
Copper
Steel

Casting
Wire Drawing
Stamping and Bending

288
124

Aluminum
Stainless Steel

Casting
Casting

510

Aluminum

Casting

16
148
37

Polyvinyl Chloride (PVC)
PVC
Steel

Plastic Injection Molding
Plastic Injection Molding
Stamping and Bending

19
41
12

Polypropylene
PVC
Polymethylmethacrylate (PMMA)

Plastic Injection Molding
Extrusion
Plastic Injection Molding

112

70% Copper / 30% PVC

Wire Drawing/Extrusion

Stator
Core
Coils
Cover
Rotor
Squirrel Cage
Ball Bearings &
Central Shaft
Suction Chamber
Fan
Fan
Fan Housing
Cross Brace
Medicine Delivery
Mouthpiece
Medical Tubing
Medicine Chamber
Power Cord
1

Not applicable (N/A) as the manufacturing process was modeled as directly combining the materials to output
the component using 0.11 MJ assembly energy input/device; 2 For a single dose.
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Throughout the model, it was assumed that the DeVilbiss Pulmo-Aide® nebulizer was constructed
out of lightweight, durable, and easily accessible materials to keep costs to a minimum. Additional
assumptions for the manufacturing and assembly of each component were made to accommodate
the LCA model by using the processes available in the GaBi database, as described in the following
sections. An assembly energy of 0.1 MJ (0.0005 MJ/dose) was used to represent manufacturing based
on other manufacturing processes built into GaBi.
2.3.1. Active Substance: Albuterol Inhalation Solution
A single dose of the albuterol sulfate inhalation solution used during device operation contains
0.003 g of albuterol sulfate, 3 g of sterile saline, and 0.000049 g of 96% sulfuric acid used to adjust
the pH from 7 to 4. The saline solution was modeled using deionized water and sodium chloride.
The solution production process included an input of 335 kJ thermal energy, as calculated to dissolve
the sodium chloride using the specific heat of water and the required change in temperature from
room temperature to boiling.
2.3.2. Exterior Shell
The outer shell of the nebulizer consists of three separate parts, all of which are composed of the
same material, and was thus modeled as a single part. Acrylonitrile butadiene styrene (ABS) material
was used to model the manufacture of the exterior shell via plastic injection molding.
2.3.3. Stator: Core, Coils and Cover
The motor’s core was manufactured using multiple steel sheets. The manufacturing process was
simplified in the GaBi model by representing the mass of the steel in the core as 80% of the combined
mass of the stator’s core and coils. The copper coils (remaining 20% of the combined mass) were
modeled by using wire drawing manufacturing. The coils and core were coated with a laminate to
improve the efficiency of the induction motor, but this coating was excluded from the model as its
mass was negligible in comparison to the total mass. The cover was modeled as steel, which was bent,
welded together, and press formed around the stator.
2.3.4. Rotor: Squirrel Cage and Ball Bearings & Central Drive Shaft
The rotor’s squirrel cage was assumed to be aluminum rather than copper composition because
it would offer a less expensive option. Rotor manufacturing was modeled by using the common die
casting process [23,24]. The mass of the squirrel cage (electromagnets) was assumed to be 70% of the
rotor’s mass, while the other 30% consisted of the ball bearings and the central drive shaft. The central
drive shaft is inserted into the rotor squirrel cage when it is hot, which allows it to shrink onto the
shaft and have a firm fit. The modeling assumption was that 0.1 MJ of electricity was input into the
system to manufacture the ball bearings and the central shaft.
2.3.5. Suction Chamber
The suction chamber was simplified by assuming it was constructed using die casting with only
aluminum materials. The rubber seal weighed less than 0.01 g (<0.0003% of device mass), and was
thus assumed to be negligible in the model.
2.3.6. Fan: Fan, Fan Housing, and Cross Brace
The fan and housing for the fan were modeled using polyvinyl chloride (PVC) granulates to
manufacture the parts using plastic injection molding. The cross brace was manufactured using steel
and was modeled using a stamping and bending method.
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2.3.7. Medicine Delivery: Mouthpiece, Medical Tubing, and Medicine Chamber
The materials used to model the mouthpiece, medical tubing, and medicine chamber were
polypropylene, PVC, and polymethylmethacrylate (PMMA), respectively. The mouthpiece and
medicine chamber manufacturing were modeled using plastic injection molding, while manufacturing
of the medical tubing was modeled using extrusion.
2.3.8. Power Cord
The power cord was modeled as copper wire surrounded by PVC tubing, with the relative
composition of the materials consisting of 70% PVC and 30% copper. In the model, the PVC tubing was
manufactured by extrusion and the copper wiring was manufactured by wire drawing. The electricity
required to manufacture the power cord was assumed to be 0.1 MJ based on other manufacturing
processes in GaBi.
2.3.9. Use Phase
During the use phase of the nebulizer, the device was modeled as requiring 60 W of power for
15 min.
Unlike the inhaler, which cannot be reused after the drug is spent, a single nebulizer is used
numerous times over its lifespan. The mouthpiece and medicine delivery components are cleaned
between each use. In this study, two different approaches to cleaning were modeled as a part of the
use phase: (1) using a dishwasher; and (2) hand cleaning. The model used a 1800 W dishwasher for
one hour, requiring 15 L (4 gallons) of tap water. All of the tap water inputs were modeled as sourced
from surface water, which is a more conservative source as it typically requires a higher degree of
treatment than groundwater. A full-capacity dishwater was assumed to use 10 g of soap. In the GaBi
model, the soap was modeled as glycerin, which is one of the products of saponification (the chemical
process used to produce soap). The mouthpiece was assumed to take up 1% of the dishwasher volume,
and materials and energy were allocated accordingly.
When the nebulizer mouthpiece was hand washed, it was assumed that 1 g of soap was used.
Additionally, 7.6 L (2 gallons) of tap water was used per minute, and 1 min was assumed for device
cleaning. After hand washing, the mouthpiece and medicine chamber are sterilized in a vinegar
solution composed of one part acetic acid (5% acidity vinegar) to three parts water. In the model,
the vinegar solution was composed of 100 g of vinegar and 300 g of tap water.
2.4. Impact Assessment
After using the inventory analysis to develop complete GaBi models representing the cradle-to-use
phases of the inhaler and nebulizer, a comparative impact assessment of GWP was performed using the
material and energy flows and environmental impacts as defined in the GaBi database. In accordance
with the ISO 14040 [7], normalization and weighting are optional components of impact assessment,
and were therefore omitted from this analysis.
2.5. Statistics
Together with the baseline scenario (best data approximations), the best and worst case uncertainty
scenarios (±100× uncertain parameters) provided three data points from which statistics were
computed at a confidence level of α = 0.05. The small sample size preempted tests for normal
distributions; however, ANOVA and Tukey post hoc tests, which assume normal distributions, were
used to test for statistically significant differences in the devices’ GWPs. All of the statistics were
performed using GraphPad Prism software.
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3. Results and Discussion
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Figure 1. Total cradle-to-use phase global warming potential (GWP) of the inhaler compared to the
Figure 1. Total cradle-to-use phase global warming potential (GWP) of the inhaler compared to the
nebulizer (cleaned using a dishwasher in comparison to hand washing). The bars illustrate the baseline
nebulizer (cleaned using a dishwasher in comparison to hand washing). The bars illustrate the
assessment, while the error bars signify the uncertainty analysis using ±100× inputs for the most
baseline assessment, while the error bars signify the uncertainty analysis using ±100× inputs for the
uncertain parameters.
most uncertain parameters.
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3.1. Uncertainty Analysis
3.1. Uncertainty Analysis
An uncertainty analysis was used to explore the potential influences of variable inputs. The best
An uncertainty analysis was used to explore the potential influences of variable inputs. The best
and worst case scenarios are illustrated by the error bars in Figure 1 (worst case: increasing all uncertain
and worst case scenarios are illustrated by the error bars in Figure 1 (worst case: increasing all
parameters 100×; best case: decreasing all uncertain parameters 100×). The greatest uncertainty in the
uncertain parameters 100×; best case: decreasing all uncertain parameters 100×). The greatest
uncertainty in the analysis stemmed from assumptions made about the individual component
manufacturing processes, as detailed in the following sections. The GWP of the device scenarios
relative to the others did not change, even assuming very high (±100×s) variation in input parameters.
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thetotal
totalGWP,
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itsGWP
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Figure 2. Relative distribution of global warming potential (GWP) associated with the major
Figure 2. Relative distribution of global warming potential (GWP) associated with the major
components of the metered dose inhaler. The three scenarios shown represent the baseline case
components of the metered dose inhaler. The three scenarios shown represent the baseline case using
using best estimates and assumptions, a worst case (100× increase in uncertain parameter inputs),
best estimates and assumptions, a worst case (100× increase in uncertain parameter inputs), and a best
and a best case (100× decrease in uncertain parameter inputs). Note that the GWP associated with the
case (100× decrease in uncertain parameter inputs). Note that the GWP associated with the active
active substance was small compared to other components, and is not visible in the figure.
substance was small compared to other components, and is not visible in the figure.

In addition to the uncertainty associated with the quantitative inputs noted above, uncertainty
In addition to the uncertainty associated with the quantitative inputs noted above, uncertainty
in the LCA model stemmed mainly from the processes used for production of albuterol and the
in the LCA model stemmed mainly from the processes used for production of albuterol and the
polymerization process of nitrile rubber. Throughout the analysis, HCFC-22 was used as the
polymerization process of nitrile rubber. Throughout the analysis, HCFC-22 was used as the
placeholder for albuterol sulfate. This modeling approach clearly introduced inaccuracy into the
placeholder for albuterol sulfate. This modeling approach clearly introduced inaccuracy into the
absolute values of the LCA model outputs; however, the GWP associated with albuterol production
absolute values of the LCA model outputs; however, the GWP associated with albuterol production
was not appreciable in the analysis as it was quite small in comparison to other components.
was not appreciable in the analysis as it was quite small in comparison to other components.
The nitrile rubber manufacturing process includes six phases (polymerization, recovery, blending,
The nitrile rubber manufacturing process includes six phases (polymerization, recovery,
coagulation, dewatering, and drying [21]), but was simplified into a single phase because the details of
blending, coagulation, dewatering, and drying [21]), but was simplified into a single phase because
the inputs and outputs of each phase could not be accurately determined. Several of the manufacturing
the details of the inputs and outputs of each phase could not be accurately determined. Several of the
processes, such as aluminum sheet stamping and bending, stainless steel deep drawing, and auto
manufacturing processes, such as aluminum sheet stamping and bending, stainless steel deep
drawing, and auto coiling were not available in GaBi; thus, the values for the inputs and outputs
were obtained from similar processes built into the database. The aluminum sheet stamping and
bending values were modeled after the steel sheet stamping and bending process. As aluminum is
less dense than steel, some of these values may actually be less. The opposite may be true for the
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coiling were not available in GaBi; thus, the values for the inputs and outputs were obtained from
similar processes built into the database. The aluminum sheet stamping and bending values were
modeled after the steel sheet stamping and bending process. As aluminum is less dense than steel,
some of these
values
Sustainability
2017, 9,
1725 may actually be less. The opposite may be true for the stainless steel
10deep
of 13
drawing, where the GaBi-defined aluminum deep drawing process was used as the model for the
steel
process.
Auto
coiling
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that bends
a steelthat
wire
into a spring,
so into
it was
the
model
for the
steel
process.
Auto coiling
is essentially
a machine
bends
steel wire
a
represented
in the
model as ainstamping
and
process.
spring,
so it was
represented
the model
as bending
a stamping
and bending process.
The materials
materials and
and associated
associated manufacturing
manufacturingprocesses
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the HFA
HFA 134a
134a propellant
propellant and
and the
the
The
polypropylene, steel, and
in in
thethe
GaBi
database;
thus
the
polypropylene,
and aluminum
aluminumcomponents
componentswere
werereadily
readilyavailable
available
GaBi
database;
thus
modeling
of
these
components
was
associated
with
low
uncertainty.
the modeling of these components was associated with low uncertainty.
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shaft), power
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shown in
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to 0.3%
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componentremained
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suggeststhat
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theLCA
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outcomemay
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Figure 3. Relative distribution of global warming potential (GWP) associated with the major
Figure 3. Relative distribution of global warming potential (GWP) associated with the major
components of the electric nebulizer. The three scenarios shown represent the baseline case using best
components of the electric nebulizer. The three scenarios shown represent the baseline case using best
estimates and assumptions, a worst case (100× increase in uncertain parameter inputs), and a best case
estimates and assumptions, a worst case (100× increase in uncertain parameter inputs), and a best case
(100× decrease in uncertain parameter inputs).
(100× decrease in uncertain parameter inputs).

In addition to the uncertainty associated in the quantitative inputs noted above, the bulk of the
In addition
to the uncertainty
associated
in the quantitative
inputs
above, the bulkofofthe
the
uncertainty
associated
with the nebulizer
analysis
was attributed
to noted
the manufacturing
uncertainty
associated
with
the
nebulizer
analysis
was
attributed
to
the
manufacturing
of
the
induction
induction motor. Most of the motor processes were not built into the GaBi database, so it was
motor. Most
the
motorinputs
processes
were not
built into the
GaBi database,
so or
it was
that the
assumed
thatof
the
system
included
the constituent
material
(e.g., steel
PVC)assumed
and electricity,
system
inputs included
the constituent
material
(e.g., steel
or PVC) andwas
electricity,
with
output
of
with
an output
of the respective
nebulizer
component.
This assumption
made for
thean
stator
coils,
the
respective
nebulizer
component.
This
assumption
was
made
for
the
stator
coils,
stator
core,
power
stator core, power cord, ball bearings, central drive shaft, and the assembly of the entire device.
cord, ball bearings, central drive shaft, and the assembly of the entire device.
3.4. Breakeven Analysis
A breakeven analysis was performed to determine the point of GWP equivalency between
cleaning the nebulizer mouthpiece using dishwashing versus by hand washing (Figure 4). Using the
baseline case (best estimates and assumptions), when the mouthpiece accounted for 10.3% of the
dishwasher load, the use phase GWP for dishwashing was equivalent to the use phase GWP for hand
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3.4. Breakeven Analysis
A breakeven analysis was performed to determine the point of GWP equivalency between
cleaning the nebulizer mouthpiece using dishwashing versus by hand washing (Figure 4). Using
the baseline case (best estimates and assumptions), when the mouthpiece accounted for 10.3% of the
dishwasher load, the use phase GWP for dishwashing was equivalent to the use phase GWP for hand
Sustainability
2017, 9, 1725 when cleaning the mouthpiece as part of a full dishwasher load (mouthpiece
11 of 13
washing. Accordingly,
accounting for <10.3% of the load), dishwashing was more effective. However, less GWP resulted
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Figure 4. Breakeven analysis showing the global warming potential (GWP) of the nebulizer cleaned
Figure
4. Breakevenasanalysis
showing
the globalof
warming
potential
of the
cleaned
in the dishwasher
a function
of proportion
dishwasher
space(GWP)
allocated
fornebulizer
the mouthpiece.
The
lines
hand washed
mouthpiece
case using best
in
thehorizontal
dishwasher
as arepresent
function three
of proportion
of dishwasher
spacescenarios:
allocated baseline
for the mouthpiece.
The
estimates and
double
andmouthpiece
soap inputs,
and half baseline
water and
soap
inputs.
horizontal
linesassumptions,
represent three
handwater
washed
scenarios:
case
using
best estimates
and assumptions, double water and soap inputs, and half water and soap inputs.

4. Conclusions
4. Conclusions
Medical device manufacturers can benefit from using life cycle assessment (LCA) to optimize
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using may
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processes
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develop
more eco-friendly
alternatives.
also be
of use to healthcare
processes
and
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more
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LCA
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that the
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use global
warming
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(GWP)
than the DeVilbiss
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Proventil
inhaler
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global than
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nebulizer.
Thefor
inhaler’s
GWP, 0.0972
CO2 -eq,
the nebulizer’s
®
(GWP)
thanuncertain
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Pulmo-Aide
electric
nebulizer.
The inhaler’s
kg CO2-eq,
was
even when
parameters
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±100
×. This finding
is basedGWP,
on the0.0972
conservative
estimate
greater
than
the
nebulizer’s
even
when
uncertain
parameters
were
varied
±100×.
This
finding
is
based
of equivalency between two inhaler puffs and a single nebulizer treatment, whereas disproportionately
on
thepuffs
conservative
of treatments
equivalency
twoasthma
inhalerexacerbations.
puffs and a single
nebulizer
more
are often estimate
needed in
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GWP
treatment,
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are often needed
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of more
severe
for the electric
nebulizer
was 0.0294 kg
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-eq, assuming
that theinmouthpiece
cleaned
in
asthma
exacerbations.
The
total
GWP
for
the
electric
nebulizer
was
0.0294
kg
CO
2
-eq,
assuming
that
a dishwasher, while it was 0.0477 kg CO2 -eq when the nebulizer mouthpiece was hand washed
the
mouthpiece
was
cleaneddifference
in a dishwasher,
while in
it the
wasdevices’
0.0477 kg
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when theproduction,
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mouthpiece
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difference
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and manufacturing)
Thebetween
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forwas
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of the GWP,
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pre-use
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production,
and
manufacturing)
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The
use
phase
of
the
inhaler
accounted
from the release of the HFA 134a propellant used to deliver the drug. When uncertain parameters were
for 96% of the GWP, stemming from the release of the HFA 134a propellant used to deliver the drug.
When uncertain parameters were adjusted ±100×, the trend in GWP among the scenarios modeled,
inhaler > hand washed nebulizer > dishwashed nebulizer remained consistent. When the mouthpiece
of the nebulizer accounted for 10% of a dishwasher load, it broke even with the GWP of the hand
washed scenario (7–17% of the dishwasher load using scenarios with double and half use of soap and
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adjusted ±100×, the trend in GWP among the scenarios modeled, inhaler > hand washed nebulizer >
dishwashed nebulizer remained consistent. When the mouthpiece of the nebulizer accounted for 10% of
a dishwasher load, it broke even with the GWP of the hand washed scenario (7–17% of the dishwasher
load using scenarios with double and half use of soap and water during handwashing, respectively).
Supplementary Materials: The following are available online at www.mdpi.com/2071-1050/9/10/1725/s1,
Figure S1: (a) DeVilbiss Pulmo-Aide® electric nebulizer and (b) Proventil® HFA metered dose inhaler, Figure S2:
LCA inventory for the manufacturing and use of a metered dose inhaler (MDI), Figure S3: LCA inventory for
the manufacturing and use of an electric nebulizer when it is washed by hand, Figure S4: LCA inventory for the
manufacturing and use of an electric nebulizer when it is washed in a dishwasher.
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